New Key Statistics Module, Z-Score and F-Score
OTCPK:PCLOF Key Ratios
| Market Cap $ M | 11.79 |
| Enterprise Value $ M | 26.28 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 6.67 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -0.07 |
| Beneish M-Score | -21.32 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 40.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.56 |
| EV-to-EBITDA | -4.07 |
| PEG | -- |
| Shares Outstanding M | 169.75 |
| Net Margin (%) | -540.32 |
| Operating Margin % | -227.61 |
| Pre-tax Margin (%) | -540.32 |
| Quick Ratio | 0.07 |
| Current Ratio | 0.15 |
| ROA % (ttm) | -63.06 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -18.52 |
| Dividend Yield % | -- |
| Altman Z-Score | -17.11 |
PCLOF Number of Guru Trades
PCLOF Volume of Guru Trades
Gurus Latest Trades with OTCPK:PCLOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:PCLOF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
PharmaCielo Ltd Insider Transactions
No Available Data
News about OTCPK:PCLOF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers